Purpura, Thrombocytopenic clinical trials

The registry lists 32 studies for Purpura, Thrombocytopenic across more than 10 countries. 6 are recruiting or about to start. 10 of them are mainly about Purpura, Thrombocytopenic (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-04. Counting its 2 narrower conditions too, such as Purpura, Thrombocytopenic, Idiopathic: 576 studies, 175 open.

Get an email when these change. Save the Purpura, Thrombocytopenic studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 21
Recruiting: 4
Status unknown: 4
Not yet recruiting: 2
Withdrawn: 1

Phase

Phase 3: 12
Phase 2: 9
Phase 1: 3
Phase 4: 1

Where

United States: 9
France: 6
Spain: 5
China: 5
Australia: 4
United Kingdom: 3

Who runs them

Amgen (9) · Takeda (2) · Kyowa Kirin Co., Ltd. (2) · Assiut University (2) · University Hospital, Toulouse (1) · Boston Children's Hospital (1) · GlaxoSmithKline (1) · Fundación Española de Hematología y Hemoterapía (1)

What is being tested here

Drugs under test in Purpura, Thrombocytopenic studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Mezagitamab	2	2	2
Romiplostim	1	7	11
Avatrombopag	1	1	1
Rituximab	1	1	1
Eltrombopag	0	0	2
Immunoglobulins, Intravenous	0	1	2
Immunoglobulin G	0	1	2
Aspirin	0	0	1
Cyclophosphamide	0	0	1
Atorvastatin	0	1	1

Coming up

3phase 3 studies under way

1study finishes main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The study

Sep 2027Romiplostim for Oral TPO-RA Resistant ITP · The First Affiliated Hospital of Soochow University

Who these studies take

Of the 4 Purpura, Thrombocytopenic studies recruiting now, 3 (75%) set no upper age limit and 0 (0%) stop at 75 or younger. 1 (25%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 4
Age	Women	Men
10	1 (25%)	1 (25%)
18	4 (100%)	4 (100%)
30	4 (100%)	4 (100%)
40	4 (100%)	4 (100%)
50	4 (100%)	4 (100%)
65	4 (100%)	4 (100%)
75	4 (100%)	4 (100%)
85	4 (100%)	4 (100%)

Across all 32 studies, recruiting or not: 22% stop at 75 or younger and 16% at 65; 38% take children; 0% are for women only and 3% for men only; 3% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 32 of 32. search them.